Effect of the dietary supplement Satisfax (Registered Trademark) on weight loss in overweight volunteers.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12614001228673

Enrollment

100

Registered

2014-11-24

Start date

2014-10-21

Completion date

2014-10-24

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary purpose of this trial is to measure the acceptability of, and compliance with regular consumption of the health supplement Satisfax and its effect on body weight in overweight volunteers over a period of 8 weeks. We hypothesize that the regular consumption of Satisfax will lead to a loss of weight in overweight volunteers.

Interventions

Intervention with Satisfax (Registered Trademark), a proprietary blend of grape and kiwifruit extract, 3 times a day prior to meals at a dose of of 2 capsules (1 gram). The treatment will be administered for 8 weeks via an oral capsule. Adherence to the treatment regime will be monitored by capsule bottle return and self reporting on line.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

BMI between 25 and 35

Exclusion criteria

Diabetic, pregnant or breast feeding

Outcome results